Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust pain relief for up to three weeks, according to the results of preclinical ...

A molecule developed by Jacobs School researchers acts like a long-lasting anesthetic, with a single, local injection providing pain relief for up to 3 weeks.

Corneal crosslinking (CXL) can be used to treat corneal neovascularization (CNV) if any causative infection is eradicated at the time of treatment or shortly thereafter, according ...

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.